Clinical Trials
Kristen is an experienced clinical trial professional with many years of experience in trial development and operations. She holds a Bachelor of Medical Science with First Class Honours and a Doctor of Philosophy (PhD) from the Faculty of Medicine at the University of Sydney. Kristen previously worked as a Research Development Lead at the University’s Clinical Trial Centre, steering trials from concept development to start-up. Kristen has worked briefly in the University’s Research Portfolio to assist the drafting of the University’s Clinical Trial Policy and Procedures. Kristen will be working on the Australian Eating Disorders Research and Translation Centre's Signature Studies at the InsideOut Institute.
Kristen's interests include design, development, and execution of large-scale research initiatives. With a special interest in novel and adaptive trial methodology projects.
The TailorED study tests innovative interventions for people with Bulimia Nervosa or Binge Eating Disorder who don't respond well to standard cognitive behavioural therapy, comparing personalised care with brain stimulation (TMS). This stepped-care approach aims to optimise treatment outcomes, reduce costs and waiting times, and provide evidence for tailoring care based on individual treatment response.
In Recruitment
This trial will develop and evaluate a personalised package of care for young people with anorexia nervosa aged 14-25 through co-production with individuals and families, with treatment tailored based on regular clinical and psychometric review.
In Recruitment
This study investigates brain and hormonal responses to real-time food consumption decisions in individuals with anorexia nervosa using brain imaging and biomarker analysis. The research aims to identify biological drivers of restrictive eating and inform development of novel treatment targets.
In Recruitment
The Holistic Understanding study is a longitudinal, biopsychosocial dense-sampling study designed to uncover the mechanisms underlying eating disorder development and maintenance, addressing gaps in current understanding that limit treatment efficacy.
In Recruitment
Low & Anaplastic Grade Glioma Umbrella Study of Molecular Guided Therapies (LUMOS-2): Study Protocol for a Phase 2, Prospective, Multicentre, Open-Label, Multiarm, Biomarker-Directed, Signal-Seeking, Umbrella, Clinical Trial for Recurrent IDH Mutant, Grade 2/3 Glioma
McParland K, Koh E, Kong B, et al
BMJ Open.
15(2).
clinical-trials
PhD in Medicine
© 2026 InsideOut
InsideOut acknowledges the tradition of custodianship and law of the Country on which the University of Sydney and Charles Perkins Centre campus stands. We pay our respects to those who have cared and continue to care for Country. We are committed to diversifying research and eliminating inequities and discrimination in healthcare. We welcome all people regardless of age, gender, race, size, sexuality, language, socioeconomic status, location or ability.